Kymera Therapeutic
Trade Kymera Therapeutic 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About KYMR
Kymera Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of human diseases through the development of innovative, highly differentiated medicines. It focuses on discovering and developing novel small-molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s natural protein degradation system.
KYMR Key Statistics
Stock Snapshot
With a market cap of 6.76B, Kymera Therapeutic(KYMR) trades at $82.80. The stock has a price-to-earnings ratio of -22.69.
During the trading session on 2026-03-09, Kymera Therapeutic(KYMR) shares reached a daily high of $85.71 and a low of $81.30. At a current price of $82.80, the stock is +1.8% higher than the low and still -3.4% under the high.
Trading activity shows a volume of 226.2K, compared to an average daily volume of 953.28K.
Over the past 52 weeks, Kymera Therapeutic(KYMR) stock has traded between a high of $103.00 and a low of $19.45.
Over the past 52 weeks, Kymera Therapeutic(KYMR) stock has traded between a high of $103.00 and a low of $19.45.
Analyst ratings
92%
of 24 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.